Ocugen Inc, a biotechnology company focused on discovering, developing, and commercializing novel gene therapies to address major blindness diseases and offer hope for patients across the globe, ...

MALVERN, Pa., June 05, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc., a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the signing of a binding term sheet to ...

Ocugen, Inc. has signed a binding term sheet to negotiate a licensing agreement for OCU400, its gene therapy for retinitis pigmentosa (RP), with a major pharmaceutical company in Korea, granting ...

1 Monaro Mining NL, 2009, 250% increase in uranium resource inventory at Rio Puerco deposit, New Mexico USA: Monaro Mining NL ASX news release: (link) 2 Boyer, D. and Ostensoe, E., 2011, NI 43-101 ...

1 Monaro Mining NL, 2009, 250% increase in uranium resource inventory at Rio Puerco deposit, New Mexico USA: Monaro Mining NL ASX news release: (link) 2 Boyer, D. and Ostensoe, E., 2011, NI 43-101 ...

HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) , today announced that it has entered into a binding term sheet with Intact Therapeutics, Inc ...

1 Monaro Mining NL, 2009, 250% increase in uranium resource inventory at Rio Puerco deposit, New Mexico USA: Monaro Mining NL ASX news release: (link) 2 Boyer, D. and Ostensoe, E., 2011, NI 43-101 ...

VANCOUVER, BC / ACCESS Newswire / June 24, 2025 / North Shore Uranium Ltd. (TSXV:NSU) (“ North Shore ” or the “ Company “) is pleased to announce that on June 23, 2025, it signed a binding term sheet ...

Historical resource estimate of 6.0 million tonnes at an average grade of 0.09% eU 3 O 8 for 11.4 million lbs. of U 3 O 8 reported in 2009 Substantial historical dataset to guide and optimize ...

Ocean Partners will exchange approximately US $14 million in existing loans for an 80% interest in Flintridge Resources Limited and an 80% interest in Omagh Minerals Ltd, subsidiaries of Galantas ...